|
| Press Releases |
|
 |
|
| Monday, June 25, 2018 |
|
|
Jacobson Pharma Announces 2018 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018").
more info >> |
|
| Thursday, June 14, 2018 |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests, is pleased to share that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score(R) results of 11 to 25. more info >> |
|
| Wednesday, June 13, 2018 |
|
|
雅各臣汇报TAILORx研究结果 |
| 雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）为全球领先的基因型诊断检测供应商Genomic Health, Inc. （「基美健」﹔纳斯达克： GHDX）的香港及澳门独家分销商，欣然分享Trial Assigning IndividuaLized Options for Treatment (Rx)或「TAILORx」研究报告 more info >> |
|
|
雅各臣匯報TAILORx研究結果 |
| 雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）為全球領先的基因型診斷檢測供應商Genomic Health, Inc. （「基美健」﹔納斯達克：GHDX）的香港及澳門獨家分銷商，欣然分享Trial Assigning IndividuaLized Options for Treatment (Rx)或 「TAILORx」研究報告 more info >> |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests more info >> |
|
| Tuesday, April 17, 2018 |
|
|
Jacobson Pharma Ranked No.1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
|
雅各臣获《FinanceAsia》杂志「2018年亚洲最佳企业选举」选为香港「最佳小型企业」首位 |
| 从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）欣然宣布集团于亚洲权威财经杂志《FinanceAsia》举办的「2018年亚洲最佳企业选举」中，于香港「最佳小型企业」排名第一。 more info >> |
|
|
雅各臣獲《FinanceAsia》雜誌「2018年亞洲最佳企業選舉」選為香港「最佳小型企業」首位 |
| 從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）欣然宣佈集團於亞洲權威財經雜誌《FinanceAsia》舉辦的「2018年亞洲最佳企業選舉」中，於香港「最佳小型企業」排名第一。 more info >> |
|
|
Jacobson Pharma Ranked No. 1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
| Wednesday, December 20, 2017 |
|
|
Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market |
| Jacobson Pharma Corporation Limited today announced that through its wholly-owned subsidiaries, Jacobson Medical (Hong Kong) Limited and Joyful Ascent Limited, it has entered into a Licensing Framework Agreement and a Capital Increase Agreement with a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. namely, Shanghai Henlius Biotech Inc., a technological leader in research and development of biosimilar antibody drugs in China. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Announcement of the Launch of Toho Entertainment Asia Operations in Singapore
Nov 2, 2024 07:00: JST
|
|
|
Announcement of the Launch of Toho Entertainment Asia Operations in Singapore
Nov 2, 2024 06:00 HKT/SGT
|
|
|
廣發証券入選首批「跨境理財通」券商業務試點名單 助力大灣區金融市場互聯互通
Nov 1, 2024 20:10 HKT/SGT
|
|
|
广发证券入选首批"跨境理财通"券商业务试点名单 助力大湾区金融市场互联互通
Nov 1, 2024 19:57 HKT/SGT
|
|
|
MWA Renews Learning and Development Contracts with Top Malaysian Institutions
Nov 1, 2024 17:00 HKT/SGT
|
|
|
JBM Healthcare Issues Positive Profit Alert
Nov 1, 2024 13:10 HKT/SGT
|
|
|
健倍苗苗發佈盈喜 預期股東應佔綜合溢利增加不少於50%
Nov 1, 2024 13:04 HKT/SGT
|
|
|
健倍苗苗发布盈喜 预期股东应占综合溢利增加不少于50%
Nov 1, 2024 12:56 HKT/SGT
|
|
|
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
Nov 1, 2024 13:56 JST
|
|
|
富士通、スーパーコンピュータ「京」や「富岳」の高速化にも寄与した演算処理技術に関する発明が、関東地方発明表彰にて「特許庁長官賞」を受賞
Nov 1, 2024 12:30: JST
|
|
|
All-New Triton Wins Golden Award at VMARK Vietnam Design Awards 2024
Nov 1, 2024 12:43 JST
|
|
|
Fujitsu's groundbreaking computing technology for accelerating scientific computing wins Japan Patent Office Commissioner's Award
Nov 1, 2024 12:24 JST
|
|
|
富士通とAMD、AIのオープン化を加速するサステナブルなコンピューティング基盤の実現に向けて戦略的協業を開始
Nov 1, 2024 10:24: JST
|
|
|
Fujitsu and AMD to begin strategic partnership to develop more sustainable computing infrastructure intended to accelerate open-source AI initiatives
Nov 1, 2024 10:45 JST
|
|
|
Tappy Technologies Unveils the World's First Fitness Ring Featuring Network Card Tokenization for Contactless Payments
Nov 1, 2024 08:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
